| CardioVascular BioTherapeutics, Inc. | |
| Cardio Vascular Bio Therapeutics - CVBT is a biopharmaceutical company established to commercialize the breakthrough therapy developed by Dr. Thomas-Joseph Stegmann to treat coronary artery disease with a process known as angiogenesis. The treatment consi | |
| Keywords : Angiogenesis, ACORD, ACORD clinical trial, ACORD clinical trials, ACORD Phase II trial, CVBT Clinical Trial, CVBT ACORD Trial, ACORD Heart Trial, New Vessel Growth, Human Growth Factors, Coronary Heart Disease, Coronary Artery Disease, Adjunct Bypass Surg |
| Last Update : | 29/December/2011 |
| Google PR : | 3 |
| Internal links : | 7 |
| External links : | 2 |
| Archive : | Check how did the site look in the past? |